4-Milliarden-Dollar-Medicare-Katastrophe: Wie Marlow Hernandez die Gesundheit von Cano zerstörte

Originaltranskript auf Englisch. Titel, Zusammenfassungen und FAQs sind übersetzt. Die vollständige Erzählung ist über YouTube-Untertitel in Ihrer Sprache verfügbar.

Am 4. Februar, 24 Uhr 24, um 16:30 Uhr Eastern Time, reichte Cano Health Incorporated freiwillige Kapitel-11-Anträge beim US-amerikanischen Insolvenzgericht für den Bezirk Delaware ein. Einkommavier Milliarden Dollar an finanzierten Schulden. Das Eigenkapital ist bis auf den letzten Cent vernichtet. Der kubanisch-amerikanische Arzt, der das Unternehmen aufgebaut hatte – Marlow Hernandez – war nicht mehr Geschäftsführer. Er war acht Monate zuvor von seinem eigenen Vorstand entlassen worden, weil er sich in der Pressemitteilung beschönigend auf die mangelnde Kooperation bei einer internen Untersuchung berief.

So verwandelte ein 43-jähriger Internist aus Pembroke Pines, Florida, den Goldrausch von Medicare Advantage innerhalb von sieben Jahren in eine Bewertung von vier, vier Milliarden Dollar. Wie er das Unternehmen in zweiunddreißig Monaten verlor. Und wie das Justizministerium letzten Oktober zu ihm kam – Überweisungsbetrug, Wertpapierbetrug, Verschwörung zum Betrug der Vereinigten Staaten. Höchststrafe: 25 Jahre.

For two decades, Medicare Advantage was the fastest-growing line item in American health care. Twenty-eight million seniors enrolled by twenty twenty-one. One-point-two trillion dollars in annual federal payments by twenty twenty-three. Private equity poured tens of billions of dollars into the primary-care clinics that captured the capitated payments. Then the Centers for Medicare and Medicaid Services rewrote the rules. And every clinic chain that had loaded up on debt and growth got the same letter at the same time. This is the story of the largest of those collapses.

Pembroke Pines, Florida. Two thousand nine. Marlow Hernandez is a twenty-six-year-old internal-medicine resident at Larkin Community Hospital, a small for-profit teaching hospital in South Miami. His parents emigrated from Cuba in the nineteen-eighties. He grew up bilingual in a working-class Hialeah household. He went to the University of Florida, then to medical school at Nova Southeastern. His residency pays roughly fifty thousand dollars. To supplement his income he takes a side job at a single-physician primary-care clinic on Pines Boulevard. The clinic serves low-income Cuban and Haitian seniors. Almost every patient is on a Humana or UnitedHealth Medicare Advantage plan.

What Hernandez observes during those evening shifts becomes the foundation of his career. Medicare Advantage is structurally different from traditional Medicare. Under the original Medicare program, doctors bill the federal government fee-for-service — one charge per office visit, one charge per procedure, one charge per test. Under Medicare Advantage, the federal government pays each plan a fixed monthly premium per enrolled patient. The plan keeps whatever it does not spend on care. Doctors who operate inside that capitated model — who control the cost of treatment — can keep the difference.

Two thousand twelve. Hernandez and two physician partners found Cano Health. A single clinic on Pines Boulevard. Bilingual reception. Spanish-language patient portals. In-house pharmacy. Transportation to and from appointments. Social-services coordination. The thesis is simple: serve dense, low-income, Spanish-speaking Medicare populations. Capture the primary-care relationship. Manage costs through preventive care. By twenty sixteen Cano operates eight clinics across Broward and Miami-Dade. Revenue: roughly fifty million dollars.

Two thousand eighteen. ITC Holdings — a Miami-based investment firm — provides growth capital. Cano begins expanding outside South Florida. Tampa. Orlando. San Antonio. Las Vegas. Albuquerque. Cano opens its first Puerto Rico clinics in twenty nineteen. The pandemic arrives. Housebound seniors enroll in Medicare Advantage at record rates. Cano's bilingual telehealth model captures a disproportionate share of new enrollment. By the fall of twenty twenty, Cano operates forty-five clinics.

November twenty twenty. Cano announces a merger with Jaws Acquisition Corporation. Jaws is a special-purpose acquisition company — a SPAC — sponsored by Barry Sternlicht, the billionaire founder of Starwood Capital. The proposed merger values Cano at four-point-four billion dollars. June third, twenty twenty-one. The merger closes. Cano lists on the New York Stock Exchange under ticker CANO. Marlow Hernandez rings the opening bell. He is forty-one years old. He owns roughly thirty percent of the company. His personal stake is worth approximately one-point-three billion dollars on day one. The Wall Street Journal calls him the new face of Hispanic primary care. He gives an interview to CNBC. He explains that Cano will reinvest the SPAC proceeds into national expansion. The capitated model, he says, will scale infinitely as long as Medicare Advantage keeps growing.

For sixteen months it does. By the end of twenty twenty-one Cano operates one hundred thirty clinics across seven states plus Puerto Rico. Twenty thousand employees. Roughly two hundred thousand Medicare Advantage members. Cano expands into Texas with the acquisition of University Health Care. It expands into Illinois with the acquisition of Doctors HealthCare Plans. The company spends roughly six hundred million dollars on acquisitions in twenty twenty-one and twenty twenty-two combined. The acquisitions are financed primarily with debt. Long-term debt grows from roughly six hundred million dollars at the SPAC close to one-point-one billion dollars by mid twenty twenty-two.

Then the rules change. Twenty twenty-two. The Centers for Medicare and Medicaid Services issues new guidance on Medicare Advantage risk-adjustment payments. Risk adjustment is the mechanism that pays plans extra money for patients with documented chronic conditions. A diabetic patient generates a higher capitated premium than a healthy patient. A patient with congestive heart failure generates a higher premium than a diabetic. The system creates a structural incentive to document as many conditions as possible — what the industry calls upcoding. CMS audits begin to find diagnosis codes on payment forms that do not appear in medical charts. The agency announces a phased reduction in risk-adjustment payments and tighter audit standards.

Cano's stock — which had traded at fifteen dollars at the SPAC merger — begins sliding through twenty twenty-two. Analysts at JP Morgan and Piper Sandler downgrade the sector. By December twenty twenty-two, CANO shares trade below two dollars. The company is hemorrhaging cash. Operating losses for twenty twenty-two total approximately four hundred forty million dollars. The new clinics in Las Vegas, San Antonio, and Albuquerque are losing money. The Texas expansion is losing money. The Illinois expansion is losing money. Only the original Florida clinics — the ones built on the bilingual urban-Hispanic model — are still profitable.

Early twenty twenty-three. A group of activist investors led by Daniel Loeb's Third Point and Owl Creek Asset Management file public letters demanding strategic alternatives. They allege the board has tolerated mismanagement. They want Marlow Hernandez removed. Inside the company, the chief operating officer — a former Humana executive named Mark Novell — has begun raising concerns to the board about a pattern of related-party transactions. Hernandez, Novell alleges, has been approving contracts with dental, pharmacy, and transportation vendors in which his immediate family members hold equity stakes. The board hires an outside law firm — Akin Gump — to conduct an internal investigation. Hernandez refuses to be interviewed under oath. He refuses to produce certain personal financial records. The investigation stalls.

June fifth, twenty twenty-three. Cano Health's board terminates Marlow Hernandez for cause. The press release is six paragraphs. It cites his refusal to cooperate with the internal investigation. It does not specify the subject. Within four weeks the details begin to surface in court filings. Mark Novell files a thirty-million-dollar civil lawsuit alleging Hernandez had personally diverted share-purchase proceeds — money Cano had paid Novell as part of an executive equity-buyback program — to a holding company controlled by Hernandez's brother-in-law. Onsite Dental, a partner that had provided in-clinic dental services across the Cano network for three years, sues Cano for seventy-two million dollars. The complaint alleges Marlow Hernandez had personally guaranteed payment terms he had no authority to authorize, and that the dental contracts had been structured to route a six-percent management fee to an LLC owned by Hernandez's wife.

The Securities and Exchange Commission opens a formal investigation in late summer. The Department of Justice begins a parallel inquiry through the Southern District of Florida. Cano's stock — now trading on the over-the-counter pink sheets under the ticker CANOQ — sinks to twelve cents. The new chief executive, Mark Kent, a turnaround specialist from Berkeley Research Group, announces a strategic-alternatives process. Cash burn is approximately twenty million dollars per month. The senior secured lenders begin demanding waterfall protection. November twenty twenty-three. In its third-quarter ten-Q, Cano warns of substantial doubt regarding its ability to continue as a going concern.

February fourth, twenty twenty-four. Cano Health Incorporated files voluntary Chapter Eleven petitions in the United States Bankruptcy Court for the District of Delaware. One-point-four billion dollars of funded debt. Four hundred clinics are consolidated to one hundred forty during the restructuring period. Twenty thousand employees are reduced to ten thousand. The plan: divest or wind down the California, Illinois, Nevada, New Mexico, Texas, and Puerto Rico operations. Retain a core of approximately one hundred profitable Florida clinics. Emerge in summer twenty twenty-four as a smaller private company.

The senior secured lenders — Macquarie Asset Management, Diameter Capital Partners, and Anchorage Capital — provide debtor-in-possession financing and negotiate to convert their pre-petition debt into equity in the reorganized entity. Common shareholders — the retail investors who had bought CANO during the SPAC frenzy — receive zero recovery. The plan is confirmed by Judge Karen Owens on July eighteenth, twenty twenty-four. Cano emerges from bankruptcy as a private company under the same name. Macquarie Asset Management holds the largest equity stake. The legacy public-company entity — which had once traded at four billion dollars — is liquidated through a wind-down trust. The trust pays approximately twenty cents on the dollar to unsecured trade creditors and nothing to former equity holders.

Marlow Hernandez was not a party to the bankruptcy. He had been gone for eight months. He sat at home in Coral Gables — protected by a non-disclosure separation agreement that had paid him roughly two million dollars — and watched his fourteen-percent personal stake in CANO common stock evaporate. By the time the Chapter Eleven plan was confirmed, his net worth on paper had fallen from one-point-three billion dollars to approximately fifteen million. The federal investigations continued. The SEC inquiry expanded to include Cano's risk-adjustment coding practices going back to twenty nineteen. The Department of Justice subpoenaed Hernandez's personal banking records, his email server, and his communications with the family members named in the Onsite Dental complaint.

October fourteenth, twenty twenty-five. The Department of Justice unseals a fourteen-count federal indictment in the Southern District of Florida. United States versus Marlow Hernandez. Wire fraud. Securities fraud. Conspiracy to defraud the United States. Conspiracy to commit health care fraud through systematic upcoding of risk-adjustment diagnoses between twenty twenty and twenty twenty-three. The indictment alleges Hernandez personally directed the medical-coding staff to apply chronic-condition diagnosis codes — diabetes, congestive heart failure, chronic obstructive pulmonary disease — to patient records without supporting documentation, generating an estimated additional two hundred forty million dollars in federal Medicare Advantage payments to Cano over four years.

The trial is scheduled to begin in summer twenty twenty-six. Hernandez has pleaded not guilty on all counts. He faces a maximum sentence of twenty-five years in federal prison. The same federal courthouse that tried Bernie Madoff's collaborators in two thousand nine will hear the case. The Cuban-American doctor from Pembroke Pines who once treated grandmothers in a strip-mall clinic — who in twenty twenty-one rang the opening bell at the New York Stock Exchange as the company he founded reached a four-point-four-billion-dollar valuation — now sits in a Coral Gables courtroom every week reviewing discovery with his criminal defense team.

The Medicare Advantage gold rush did not end with Cano. Several smaller capitated-provider chains — Babylon Health, Bright Health, Iora Health's parent company — have followed Cano into bankruptcy or fire-sale acquisitions between twenty twenty-two and twenty twenty-five. The pattern is the same. SPAC-era valuations build on the assumption that CMS will keep paying the upcoded premium. CMS rewrites the rules. The valuations collapse. The founders sell at the top. The retail investors and the unsecured creditors absorb the wreckage. Sixteen years earlier, Marlow Hernandez had been earning fifty thousand dollars a year and treating uninsured grandmothers in a Pembroke Pines strip mall. He built a billion-dollar empire by understanding how Medicare Advantage worked better than anyone else in his city. Then he watched the federal government rewrite the rules he had built it on. And then he watched his own board fire him for the way he had built it.

The gold rush is over. The federal prosecutors are not.